Zobrazeno 1 - 10
of 183
pro vyhledávání: '"MJ Borad"'
Publikováno v:
Value in Health. 25:S33
Autor:
Davar D; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA davard@upmc.edu., Carneiro BA; Lifespan Cancer Institute, Legorreta Cancer Institute at Brown University, Providence, Rhode Island, USA., Dy GK; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Sheth S; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Borad MJ; Mayo Clinic, Phoenix, Arizona, USA., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research / The Royal Marsden NIHR Biomedical Research Centre, London, UK., Patel SP; University of California San Diego, La Jolla, California, USA., Galanis E; Mayo Clinic Rochester, Rochester, Minnesota, USA., Samson A; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK., Agrawal S; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Chen Z; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences (CPSS), BioPharmaceuticals R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Fan C; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (CPSS), BioPharmaceuticals R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Gong M; AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Burton J; Oncology R&D, AstraZeneca PLC, Cambridge, Cambridgeshire, UK., Tu E; Translational Medicine, Cell Therapy and Oncolytic Viruses, BioPharmaceuticals R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Durham N; Translational Medicine, Cell Therapy and Oncolytic Viruses, BioPharmaceuticals R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Laubscher K; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Arnaldez F; Clinical Development, Oncology R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA., Zamarin D; Early Drug Development, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 17; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 17.
Autor:
Uson Junior PLS; Division of Hematology/Oncology, Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ, USA.; Division of Hematology/Oncology, Hospital do Coração, HCOR, Sao Paulo, Brazil.; Center for Personalized Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Borad MJ; Division of Hematology/Oncology, Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ, USA.
Publikováno v:
Translational cancer research [Transl Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 4510-4513. Date of Electronic Publication: 2024 Sep 27.
Autor:
Elhariri A; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Patel J; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Mahadevia H; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Albelal D; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Ahmed AK; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Jones JC; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Borad MJ; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Babiker H; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. babiker.hani@mayo.edu.
Publikováno v:
Targeted oncology [Target Oncol] 2024 Sep; Vol. 19 (5), pp. 679-689. Date of Electronic Publication: 2024 Aug 10.
Autor:
Eslinger C; Department of Hematology-Oncology, Mayo Clinic Arizona, Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, USA., Uson PLS Jr; Department of Hematology-Oncology, Mayo Clinic Arizona, Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, USA., Nagalo BM; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Borad MJ; Department of Hematology-Oncology, Mayo Clinic Arizona, Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, USA.
Publikováno v:
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Aug 31; Vol. 15 (4), pp. 1933-1938. Date of Electronic Publication: 2024 Jul 22.
Autor:
Ueberroth BE; Department of Hematology/Oncology, University of Colorado Anschutz School of Medicine, Aurora, CO, United States., Presutti RJ; Department of Family Medicine, Mayo Clinic, Jacksonville, FL, United States., McGary A; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, United States., Borad MJ; Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, United States., Agrwal N; Department of Medicine, Mayo Clinic, Phoenix, AZ, United States.
Publikováno v:
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2024 Aug 23; Vol. 22, pp. eAO0771. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).
Autor:
Borad MJ; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona, United States of America.; Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona, United States of America.; Center for Individualized Medicine, Rochester, Minnesota, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Jul 31; Vol. 19 (7), pp. e0308087. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).
Autor:
Webb MJ; Department of Hematology/Medical Oncology, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Sangsuwannukul T; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., van Vloten J; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Evgin L; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, V5Z1L3, Canada.; Michael Smith Genome Sciences Department, BC Cancer Research Institute, Vancouver, BC, V5Z1L3, Canada., Kendall B; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Tonne J; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Thompson J; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Metko M; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Moore M; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA., Chiriboga Yerovi MP; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Olin M; Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN, 55455, USA., Borgatti A; Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, MN, 55108, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.; Clinical Investigation Center, University of Minnesota, St. Paul, MN, 55108, USA., McNiven M; Mayo Center for Biomedical Discovery, Mayo Clinic, Rochester, MN, 55905, USA., Monga SPS; Pittsburgh Liver Institute, University of Pittsburgh and UPMC, Pittsburgh, PA, 15261, USA., Borad MJ; Department of Hematology/Medical Oncology, Mayo Clinic, Phoenix, AZ, 85054, USA., Melcher A; Division of Radiotherapy and Imaging, Institute of Cancer Research, Chester Beatty Laboratories, London, SW3 6JB, UK., Roberts LR; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55905, USA., Vile R; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, 55905, USA. vile.richard@mayo.edu.; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA. vile.richard@mayo.edu.; Joan Reece Department of Immuno-oncology, King's College London, London, UK. vile.richard@mayo.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 27; Vol. 15 (1), pp. 5442. Date of Electronic Publication: 2024 Jun 27.
Autor:
Vogel A; Hannover Medical School, Hannover, Germany; Toronto General Hospital, Toronto; Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: vogela@me.com., Sahai V; University of Michigan, Ann Arbor, USA., Hollebecque A; Gustave Roussy Cancer Center, Paris, France., Vaccaro GM; Providence Cancer Center, Portland, USA., Melisi D; Università degli studi di Verona, Verona, Italy., Al Rajabi RM; University of Kansas Medical Center, Kansas City., Paulson AS; Baylor University Medical Center, Dallas., Borad MJ; Mayo Clinic Cancer Center, Phoenix., Gallinson D; Morristown Memorial Hospital, Morristown., Murphy AG; Johns Hopkins University School of Medicine, Baltimore, USA., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea., Dotan E; Fox Chase Cancer Center, Philadelphia., Catenacci DV; University of Chicago Medicine, Chicago, USA., Van Cutsem E; University Hospitals Gasthuisberg, Leuven & University of Leuven, Leuven, Belgium., Lihou CF; Incyte Corporation, Wilmington, USA., Zhen H; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York; Weill Medical College at Cornell University, New York, USA; Trinity College Dublin School of Medicine, Dublin, Ireland.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103488. Date of Electronic Publication: 2024 Jun 04.
Autor:
Garmezy B; Sarah Cannon Research Institute, Nashville, Tennessee., Borad MJ; Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona., Bahleda R; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France., Perez CA; Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida., Chen LT; Kaohsiung Medical University Hospital and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan., Kato S; Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of South Korea., Severson P; Kinnate Biopharma, San Francisco, California., Tam BY; Formerly Kinnate Biopharma, San Francisco, California., Quah CS; Kinnate Biopharma, San Francisco, California., Harding JJ; Gastrointestinal Oncology and Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Apr 30; Vol. 4 (4), pp. 1165-1173.